Bevacizumab for neovascular age-related macular degeneration using a treat-and-extend regimen: clinical and economic impact (Q51171123)

From Wikidata
Jump to navigation Jump to search
scientific article published on October 11, 2011
edit
Language Label Description Also known as
English
Bevacizumab for neovascular age-related macular degeneration using a treat-and-extend regimen: clinical and economic impact
scientific article published on October 11, 2011

    Statements

    Bevacizumab for neovascular age-related macular degeneration using a treat-and-extend regimen: clinical and economic impact (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit